Assessing the utility of molecular diagnostic classification for cancers of unknown primary

BACKGROUND: Roughly 5% of metastatic cancers present with uncertain origin, for which molecular classification could influence subsequent management; however, prior studies of molecular diagnostic classifiers have reported mixed results with regard to clinical impact. In this retrospective study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Elle C., Blobe, Gerard C., DeVito, Nicholas C., Hanks, Brent A., Harrison, Michael R., Hoimes, Christopher J., Jia, Jingquan, Morse, Michael A., Jayaprakasan, Parvathy, MacKelfresh, Andrew, Mulder, Hillary, Hockenberry, Adam J., Zander, Alia, Stumpe, Martin C., Michuda, Jackson, Beauchamp, Kyle A., Perakslis, Eric, Taxter, Timothy, George, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587948/
https://www.ncbi.nlm.nih.gov/pubmed/37712677
http://dx.doi.org/10.1002/cam4.6532

Ejemplares similares

Ejemplares similares